Buprenorphine vs Ipilimumab

## Buprenorphine vs Ipilimumab: Overview

This comparison examines the pharmacological differences between **Buprenorphine** and **Ipilimumab**.

## Mechanism of Action

**Buprenorphine**: Partial mu-opioid receptor agonist and kappa antagonist with high receptor affinity.

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

## Pharmacokinetics

**Half-life**: Buprenorphine — 24-42 hours; Ipilimumab — 14.7 days.

## Chemical Properties

**Molecular Formula**: Buprenorphine — C29H41NO4; Ipilimumab — N/A.

**Molecular Weight**: Buprenorphine — 467.6430 g/mol; Ipilimumab — N/A.

**Type**: Buprenorphine — Small molecule; Ipilimumab — Antibody.